Article

Molecular profiling of lung cancer

2014-01-01

Abstract excerpt

Cisplatin is a first line chemotherapeutic agent for lung cancer however, although patients may respond to therapy, resistance often develops with tumour recurrence and disease progression. Somatic alterations in the tumour may alter therapeutic responses. Consequently a model of cisplatin resistance in lung cancer derived A549 cells has been created to examine the genomic changes that occur as chemo-resistance de...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 89823ed8-382b-57a2-a5ad-1455e158ea64
DOI: 10.25560/24546

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Molecular profiling of lung cancerDOI 10.25560/24546Read

Transcriptome Sequencing Reveals Key Pathways and Genes Associated with Cisplatin Resistance in Lung Adenocarcinoma A549 CellsSemantic proximity Read

Applications of Machine Learning to Predict Cisplatin Resistance in Lung CancerSemantic proximity Read

Applications of Machine Learning to Predict Cisplatin Resistance in Lung CancerSemantic proximity Read

Regulation of cisplatin resistance in lung cancer by epigenetic mechanismsSemantic proximity Read

Cisplatin resistance in human lung cancer cells is linked with dysregulation of cell cycle associated proteinsSemantic proximity Read

MiR-320a is associated with cisplatin resistance in lung adenocarcinoma and its clinical value in non-small cell lung cancer: A comprehensive analysis based on microarray dataSemantic proximity Read

Drug resistance in lung cancerSemantic proximity Read

Longitudinal single-cell RNA model aids prediction of EGFR-TKI resistance.Semantic proximity Read

Drug Resistance in NSCLC is Associated with Tumor Micro-environmentSemantic proximity Read

Cancer cells acquire resistance to anticancer drugs: an update.Semantic proximity Read

Drug resistance in non-small cell lung Cancer (NSCLC): Impact of genetic and non-genetic alterations on therapeutic regimen and responsivenessSemantic proximity Read

Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC)Semantic proximity Read